BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34725378)

  • 1. Metabolomic profiling of Burkholderia cenocepacia in synthetic cystic fibrosis sputum medium reveals nutrient environment-specific production of virulence factors.
    Jaiyesimi OA; McAvoy AC; Fogg DN; Garg N
    Sci Rep; 2021 Nov; 11(1):21419. PubMed ID: 34725378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of Quorum Sensing and Virulence in
    Cui C; Song S; Yang C; Sun X; Huang Y; Li K; Zhao S; Zhang Y; Deng Y
    Appl Environ Microbiol; 2019 Apr; 85(8):. PubMed ID: 30770405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Cystic Fibrosis-Associated
    McAvoy AC; Jaiyesimi O; Threatt PH; Seladi T; Goldberg JB; da Silva RR; Garg N
    ACS Infect Dis; 2020 May; 6(5):1154-1168. PubMed ID: 32212725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic Cystic Fibrosis Sputum Medium Regulates Flagellar Biosynthesis through the flhF Gene in Burkholderia cenocepacia.
    Kumar B; Cardona ST
    Front Cell Infect Microbiol; 2016; 6():65. PubMed ID: 27379216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Burkholderia cenocepacia Type VI Secretion System Effector TecA Is a Virulence Factor in Mouse Models of Lung Infection.
    Loeven NA; Perault AI; Cotter PA; Hodges CA; Schwartzman JD; Hampton TH; Bliska JB
    mBio; 2021 Oct; 12(5):e0209821. PubMed ID: 34579569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic cystic fibrosis sputum medium diminishes Burkholderia cenocepacia antifungal activity against Aspergillus fumigatus independently of phenylacetic acid production.
    Lightly TJ; Phung RR; Sorensen JL; Cardona ST
    Can J Microbiol; 2017 May; 63(5):427-438. PubMed ID: 28178425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A c-di-GMP-Modulating Protein Regulates Swimming Motility of
    Kumar B; Sorensen JL; Cardona ST
    Front Cell Infect Microbiol; 2018; 8():56. PubMed ID: 29541628
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel method for investigating Burkholderia cenocepacia infections in patients with cystic fibrosis and other chronic diseases of the airways.
    Wijers CD; Vagedes R; Weingart C
    BMC Microbiol; 2016 Sep; 16(1):200. PubMed ID: 27586172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The attenuated virulence of a Burkholderia cenocepacia paaABCDE mutant is due to inhibition of quorum sensing by release of phenylacetic acid.
    Pribytkova T; Lightly TJ; Kumar B; Bernier SP; Sorensen JL; Surette MG; Cardona ST
    Mol Microbiol; 2014 Nov; 94(3):522-36. PubMed ID: 25155974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylacetyl Coenzyme A, Not Phenylacetic Acid, Attenuates CepIR-Regulated Virulence in Burkholderia cenocepacia.
    Lightly TJ; Frejuk KL; Groleau MC; Chiarelli LR; Ras C; Buroni S; Déziel E; Sorensen JL; Cardona ST
    Appl Environ Microbiol; 2019 Dec; 85(24):. PubMed ID: 31585996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acidic pH modulates
    Morales LD; Av-Gay Y; Murphy MEP
    Microbiol Spectr; 2023 Dec; 11(6):e0273123. PubMed ID: 37966209
    [No Abstract]   [Full Text] [Related]  

  • 12. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
    Drevinek P; Mahenthiralingam E
    Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oridonin Attenuates Burkholderia cenocepacia Virulence by Suppressing Quorum-Sensing Signaling.
    Li X; Wang K; Wang G; Cui B; Song S; Sun X; Deng Y
    Microbiol Spectr; 2022 Aug; 10(4):e0178722. PubMed ID: 35856676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia.
    Scoffone VC; Barbieri G; Buroni S; Scarselli M; Pizza M; Rappuoli R; Riccardi G
    Trends Microbiol; 2020 Apr; 28(4):315-326. PubMed ID: 31932141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyramine, one quorum sensing inhibitor, reduces pathogenicity and restores tetracycline susceptibility in Burkholderia cenocepacia.
    Yin L; Wang Y; Xiang S; Xu K; Wang B; Jia AQ
    Biochem Pharmacol; 2023 Dec; 218():115906. PubMed ID: 37951366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: The Conundrum of What to Pick? Antibiotic Susceptibility Variability in
    Moore JE; McCaughan J; Rendall JC; Millar BC
    Br J Biomed Sci; 2024; 81():12749. PubMed ID: 38895586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burkholderia cenocepacia phenotypic clonal variation during a 3.5-year colonization in the lungs of a cystic fibrosis patient.
    Coutinho CP; de Carvalho CC; Madeira A; Pinto-de-Oliveira A; Sá-Correia I
    Infect Immun; 2011 Jul; 79(7):2950-60. PubMed ID: 21536796
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Willsey GG; Eckstrom K; LaBauve AE; Hinkel LA; Schutz K; Meagher RJ; LiPuma JJ; Wargo MJ
    J Bacteriol; 2019 Aug; 201(15):. PubMed ID: 31109991
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation of the multifaceted iron acquisition strategies of Burkholderia cenocepacia.
    Tyrrell J; Whelan N; Wright C; Sá-Correia I; McClean S; Thomas M; Callaghan M
    Biometals; 2015 Apr; 28(2):367-80. PubMed ID: 25725797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic analysis of Burkholderia cenocepacia isolated from a liver abscess in a patient with cystic fibrosis.
    de Freitas Vianna E; Menezes NIM; de Almeida MM; de Freitas FAD; da Costa Ferreira Leite C; Firmida MC; de Medeiros DRI; Souza Leão R; Mattos Albano R; Andrade Marques E
    APMIS; 2021 Nov; 129(11):631-640. PubMed ID: 34561922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.